Total iron binding capacity and transferrin concentration in the assessment of iron status

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 10, 2002, Pages 1014-1018

  Kasvosve, Ishmael ^a   Delanghe, Joris ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Hemochromatosis; Iron; Iron overload; Total iron binding capacity; Transferrin

Indexed keywords

ALBUMIN; IRON; PLASMA PROTEIN; TRANSFERRIN;

ANALYTIC METHOD; ANALYTICAL ERROR; CONTROLLED STUDY; CORRELATION FUNCTION; COST BENEFIT ANALYSIS; EUROPE; GENETIC VARIABILITY; HUMAN; IMMUNOHISTOCHEMISTRY; IRON BINDING CAPACITY; LABORATORY TEST; MEASUREMENT; MEDICAL LITERATURE; PLASMA PROTEIN BINDING; POPULATION RESEARCH; PRIORITY JOURNAL; REFERENCE VALUE; REVIEW; STANDARD; TRANSFERRIN BLOOD LEVEL; BLOOD; CAPILLARY ELECTROPHORESIS; GENETIC POLYMORPHISM; GENETICS; HEMOCHROMATOSIS; IMMUNOCHEMISTRY; METABOLISM;

BLOOD PROTEINS; ELECTROPHORESIS, CAPILLARY; HEMOCHROMATOSIS; HUMANS; IMMUNOCHEMISTRY; IRON; POLYMORPHISM, GENETIC; TRANSFERRIN;

EID: 0036429444     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.176     Document Type: Review

References (48)

1. DeMaeyer E, Adiel-Tegman M. The prevalence of anaemia in the world. World Health Stat Q 1985; 38:302-16.
2. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999; 341:1986-95.
3. Powell LW, George DK, McDonnell SM, Kowdley KV. Diagnosis of hemochromatosis. Ann Intern Med 1998; 129:925-31.
4. Gordeuk VR. Hereditary and nutritional iron overload. Baillieres Clin Haematol 1992; 5:169-86.
5. Kasvosve I, Gomo ZAR, Gordeuk VR, Gangaidzo IT. African iron overload. Acta Clin Belg 2000; 55:88-93.
6. Sherwood RA, Pippard MJ, Peters TJ. Iron homeostasis and the assessment of iron status. Ann Clin Biochem 1998; 35:693-708.
7. Worwood M. The laboratory assessment of iron status-an update. Clin Chim Acta 1997; 259:3-23.
8. Ramsay WNM. The determination of the total iron-binding capacity of serum. Clin Chim Acta 1957; 259:25-30.
9. Bassett ML, Halliday JW, Ferris RA, Powell LW. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. Gastroenterology 1984; 87:628-33.
10. MacPhail AP, Mandishona EM, Bloom PD, Paterson AC, Rouault TA, Gordeuk VR. Mesurements of iron status and survival in African iron overload. S Afr Med J 1999; 89:966-72.
11. Fairbanks VF, Klee GG. Biochemical aspects of haematology. In: Burtis CA, Ashwood ER, editors. Tietz textbook of clinical chemistry, 3rd ed. Philadelphia: W.B. Saunders Company, 1999:1703.
12. Beilby J, Olynyk J, Ching S, Prins A, Swanson N, Reed W, et al. Transferrin index: an alternative method for calculating the iron saturation of transferrin. Clin Chem 1992; 38:2078-81.
13. Kasvosve I, Delanghe J, Gomo ZAR, Gangaidzo IT, Khumalo H, Wuyts B, et al. Transferrin polymorphism influences iron status in blacks. Clin Chem 2000; 46:1535-9.
14. Bothwell TH, Jacobs RW, Kamener R. The determination of the unsaturated iron-binding capacity of serum using radioactive iron. S Afr J Med Sci 1959; 24:93-8.
15. International Committee for Standardisation in Haematology (Iron Panel). The measurement of total and unsaturated iron binding capacity in serum. Br J Haematol 1978; 38:281-90.
16. Iron Panel of the International Committee for Standardisation in Haematology. Revised recommendations for the measurements of the serum iron in human blood. Br J Haematol 1990; 75:615-6.
17. Jacobs JC, Alexander NM. Colorimetry and constant-potential coulometry determinations of transferrin-bound iron, total iron-binding capacity, and total iron in serum containing iron-dextran, the use of sodium dithionite and alumina columns. Clin Chem 1990; 36:1803-7.
18. Yamanishi H, Kimura S, Iyama S, Yamaguchi Y, Yanagihara T. Fully automated measurement of total iron-binding capacity in serum. Clin Chem 1997; 43:2413-7.
19. Siek G, Lawlor J, Pelczar D, Sane M, Musto J. Direct serum total iron-binding capacity suitable for automated analyzers. Clin Chem 2002; 48:161-6.
20. Putman FW. Transferrin. In: Putman FW, editor. The plasma proteins, Vol. II, 2nd ed. New York: Academic Press, 1975:265-316.
21. Gambino R, Desvarieux E, Orth M, Matan H, Ackattupathil T, Lijoi E, et al. The relation between chemically measured total iron-binding capacity concentrations and immunologically measured transferrin concentrations in human serum. Clin Chem 1997; 43:2408-12.
22. Tsung SH, Rosenthal WA, Milewski KA. Immunological measurement of transferrin compared with chemical measurement of total iron-binding capacity. Clin Chem 1975; 21:1063-6.
23. Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2:235-54.
24. Kreutzer HJ. An immunological turbidimetric method for serum transferrin determination. J Clin Chem Clin Biochem 1976; 14:401-6.
25. Buffone GJ, Lewis SA, Iosefsohn M, Hicks JM. Chemical and immunochemical measurement of total iron-binding capacity compared. Clin Chem 1978; 24:1788-91.
26. Whicher JT, Ritchie RF, Johnson AM, Baudner S, Bienvenu J, Blirup-Jensen S, et al. New international reference preparation for proteins in human serum (RPPHS). Clin Chem 1994; 40:934-8.
27. Itoh Y, Ichihara K. Standardization of immunoassay for CRM-related proteins in Japan: from evaluating CRM 470 to setting reference intervals. Clin Chem Lab Med 2001; 39:1154-61.
28. Johnson AM, Whicher JT. Effect of certified reference material 470 (CRM 470) on national quality assurance programs for serum proteins in Europe. Clin Chem Lab Med 2001; 39:1123-8.
29. Ross JW, Fraser MD. Analytical goals developed from the inherent error of medical tests. Clin Chem 1993; 39:1481-93.
30. Dati F, Schumann G, Thomas L, Aguzzi F, Baudner S, Bienvenu J, et al. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardisation against the IFCC/BCR/CAP reference material (CRM 470). Eur J Clin Chem Clin Biochem 1996; 34:517-20.
31. Cavalli-Sforza L, Menozzi P, Piazza A. The history and the geography of human genes. Princeton, NJ: Princeton University Press, 1994:188.
32. Lee PL, Halloran C, Beutler E. Polymorphisms in the transferrin 5′ flanking region associates with differences in total iron binding capacity: possible implications in iron homeostasis. Blood Cells Mol Dis 2001; 27:539-48.
33. Helander A. Absolute or relative measurement of carbohydrate deficient transferrin in serum? Experiences with threee immunological assays. Clin Chem 1999; 45:131-5.
34. Thomas L. Transferrin-Sättigung. In: Thomas L, editor. Labor und Diagnose, 5th ed. Frankfurt/Main: TH-Books, 1998: 282-4.
35. Awad MO, Barford AV, Grindulis KA, Montgomery RD, Sammons HG. Factors affecting the serum iron-binding capacity in the elderly. Gerontology 1982; 28:125-31.
36. Loban A, Kime R, Powers H. Iron-binding antioxidant potential of plasma albumin. Clin Sci 1997; 93:445-51.
37. Ritchie RF, Whitley RJ. Proteins. In: Tietz NW, editor. Clinical guide to laboratory tests, 3rd ed. Philadelphia: W.B. Saunders Company, 1995: 605.
38. de Jong G, van Dijk JP, van Eijk HG. The biology of transferrin. Clin Chim Acta 1990; 190:1-46.
39. Gottschalk R, Wigand R, Dietrich C, Oremek G, Liebisch F, Hoelzer D, et al. Total iron-binding capacity and serum transferrin determination under the influence of several clinical conditions. Clin Chim Acta 2000; 293:127-38.
40. Rajamaki A, Irjala K, Aito A. Immunochemical determination of serum transferrin. Reference values, correlation with serum total iron-binding capacity and value in diagnosis of iron deficiency anemia of chronic disorders. Scand J Haematol 1979; 23:227-31.
41. van der Heul C, van Eijk HG, Wiltink WF, Leijnse B. The binding of iron to transferrin and to other serum components at different degrees of saturation with iron. Clin Chim Acta 1972; 38:347-53.
42. Buffone GJ, Beck JR. Cost-effectiveness analysis for evaluation of screening programs: hereditary hemochromatosis. Clin Chem 1994; 40:1631-6.
43. McLaren CE, McLachlan GJ, Haliday JW, Webb SI, Leggett BA, Jazwinska EC, et al. Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology 1998; 114:543-9.
44. Oliva G, Dominici G, Latini P, Cozzolino G. Sindrome nefrosica atransferrinemica. Minerva Med 1968; 59:1297-309.
45. Gaston-Morata JL, Rodriguez-Cuartero A, Urbano-Jiminez F. Atransferrinaemia secundaria a cirrosis hepàtica, hemocromatosis y sindromenefrotico. Rev Esp Enferm Apar Dig 1960; 62:491.
46. Westerhausen M, Meuret G. Transferrin-immune complex disease. Acta Haematol 1977; 57:96-101.
47. Hamill RL, Woods JC, Cook BA. Congenital atransferrinemia. A case report and review of the literature. Am J Clin Pathol 1991; 96:215-8.
48. Walbaum R. Congenital transferrin deficiency. Lille Med 1971; 16:1122-4.